Nicolas GP - Search Results

1

New Gastrin Releasing Peptide Receptor-Directed [^99mTc]Demobesin 1 Mimics: Synthesis and Comparative Evaluation.

Nock BA, Charalambidis D, Sallegger W, Waser B, Mansi R, Nicolas GP, Ketani E, Nikolopoulou A, Fani M, Reubi JC, Maina T. Nock BA, et al. Among authors: nicolas gp. J Med Chem. 2018 Apr 12;61(7):3138-3150. doi: 10.1021/acs.jmedchem.8b00177. Epub 2018 Mar 19. J Med Chem. 2018. PMID: 29517903

2

Development of new folate-based PET radiotracers: preclinical evaluation of ⁶⁸Ga-DOTA-folate conjugates.

Fani M, Wang X, Nicolas G, Medina C, Raynal I, Port M, Maecke HR. Fani M, et al. Eur J Nucl Med Mol Imaging. 2011 Jan;38(1):108-19. doi: 10.1007/s00259-010-1597-8. Epub 2010 Aug 27. Eur J Nucl Med Mol Imaging. 2011. PMID: 20799032

3

Radiolabeled bicyclic somatostatin-based analogs: a novel class of potential radiotracers for SPECT/PET of neuroendocrine tumors.

Fani M, Mueller A, Tamma ML, Nicolas G, Rink HR, Cescato R, Reubi JC, Maecke HR. Fani M, et al. J Nucl Med. 2010 Nov;51(11):1771-9. doi: 10.2967/jnumed.110.076695. Epub 2010 Oct 18. J Nucl Med. 2010. PMID: 20956465 Free article.

4

Bombesin antagonist-based radioligands for translational nuclear imaging of gastrin-releasing peptide receptor-positive tumors.

Abiraj K, Mansi R, Tamma ML, Fani M, Forrer F, Nicolas G, Cescato R, Reubi JC, Maecke HR. Abiraj K, et al. J Nucl Med. 2011 Dec;52(12):1970-8. doi: 10.2967/jnumed.111.094375. Epub 2011 Nov 11. J Nucl Med. 2011. PMID: 22080443 Free article.

5

In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates.

Fani M, Tamma ML, Nicolas GP, Lasri E, Medina C, Raynal I, Port M, Weber WA, Maecke HR. Fani M, et al. Among authors: nicolas gp. Mol Pharm. 2012 May 7;9(5):1136-45. doi: 10.1021/mp200418f. Epub 2012 Apr 23. Mol Pharm. 2012. PMID: 22497506

6

Localization of Hidden Insulinomas with ⁶⁸Ga-DOTA-Exendin-4 PET/CT: A Pilot Study.

Antwi K, Fani M, Nicolas G, Rottenburger C, Heye T, Reubi JC, Gloor B, Christ E, Wild D. Antwi K, et al. J Nucl Med. 2015 Jul;56(7):1075-8. doi: 10.2967/jnumed.115.157768. Epub 2015 May 21. J Nucl Med. 2015. PMID: 25999434 Free article. Clinical Trial.

7

Biodistribution, Pharmacokinetics, and Dosimetry of ¹⁷⁷Lu-, ⁹⁰Y-, and ¹¹¹In-Labeled Somatostatin Receptor Antagonist OPS201 in Comparison to the Agonist ¹⁷⁷Lu-DOTATATE: The Mass Effect.

Nicolas GP, Mansi R, McDougall L, Kaufmann J, Bouterfa H, Wild D, Fani M. Nicolas GP, et al. J Nucl Med. 2017 Sep;58(9):1435-1441. doi: 10.2967/jnumed.117.191684. Epub 2017 Apr 27. J Nucl Med. 2017. PMID: 28450554 Free article.

8

Somatostatin Receptor Antagonists for Imaging and Therapy.

Fani M, Nicolas GP, Wild D. Fani M, et al. Among authors: nicolas gp. J Nucl Med. 2017 Sep;58(Suppl 2):61S-66S. doi: 10.2967/jnumed.116.186783. J Nucl Med. 2017. PMID: 28864614 Free article. Review.

9

Safety, Biodistribution, and Radiation Dosimetry of ⁶⁸Ga-OPS202 in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase I Imaging Study.

Nicolas GP, Beykan S, Bouterfa H, Kaufmann J, Bauman A, Lassmann M, Reubi JC, Rivier JEF, Maecke HR, Fani M, Wild D. Nicolas GP, et al. J Nucl Med. 2018 Jun;59(6):909-914. doi: 10.2967/jnumed.117.199737. Epub 2017 Oct 12. J Nucl Med. 2018. PMID: 29025985 Free article. Clinical Trial.

10

Reply: Advantages and Limits of Targeted Radionuclide Therapy with Somatostatin Antagonists.

Nicolas GP, Wild D, Fani M. Nicolas GP, et al. J Nucl Med. 2018 Mar;59(3):547-548. doi: 10.2967/jnumed.117.203703. Epub 2017 Nov 16. J Nucl Med. 2018. PMID: 29146693 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters